Galmed Pharmaceuticals Ltd. buy Piper Sandler
Start price
20.05.24
/
50%
€0.37
Target price
20.05.25
€73.65
Performance (%)
1648.63%
End price
21.05.25
-
Summary
This prediction is currently being closed. The BUY prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd. has seen massive gains of 1648.63%. Piper_Sandler has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1.596% | 1.524% | 3.017% |
| iShares Nasdaq 100 | 1.432% | 1.156% | 32.579% |
| iShares Nikkei 225® | 1.108% | 1.735% | 60.582% |
| iShares S&P 500 | 0.528% | 2.967% | 24.136% |
Comments by Piper_Sandler for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Stopped prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
15.06.26
15.06.26
€86.10
15.06.27
15.06.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
09.05.25
09.05.25
€71.34
09.05.26
09.05.26
-
10.05.26
10.05.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€93.31
06.11.25
06.11.25
-
07.11.25
07.11.25